Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Bouaynaya’s appointment represents a significant investment in leveraging AI to drive Rowan University's strategic growth. As ...

Two final-year Medicine students design consultation tools thanks to a grant from the Cris Foundation against Cancer. After a cancer diagnosis, it is inevitable to type the type on the internet and ...

Dr. Koushik Kasanagottu, a public health expert and assistant clinical professor in the Department of Internal Medicine at ...

The global incidence of cancer reached 20 million in 2022 and is projected to rise to 33·1 million by 2050.1 Amid the growing ...

Highlights the role of artificial intelligence in early rare disease detection, diagnosis, and treatment, with the ...

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease.

Two things can be true: Holding back Chinese technology like DeepSeek and TikTok could be good for America, but it also hurts America. The developer of the chatbot that shocked U.S. incumbents had ...

A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...

Artificial intelligence is playing a growing role in medical care, and it could soon be coming to your doctor's office.

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease. However, these few ...